Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study
Arlene D’Silva, Didu Kariyawasam, Pooja Venkat, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 170-170
Open Access | Times Cited: 13

Showing 13 citing articles:

Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Emerging Gene Therapy Approaches in the Management of Spinal Muscular Atrophy (SMA): An Overview of Clinical Trials and Patent Landscape
Aleksei S. Ponomarev, Daria S. Chulpanova, Lina M. Yanygina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13743-13743
Open Access | Times Cited: 16
Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
Yu‐Fu Wu, Jun‐An Chen, Yuh‐Jyh Jong
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective
Lakshmi Balaji, Michelle A. Farrar, Arlene D’Silva, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 7, pp. 571-586
Closed Access | Times Cited: 8
Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Giorgia Querin, M. Gómez García de la Banda, Piera Smeriglio
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
270th ENMC International Workshop: Consensus for SMN2 genetic analysis in SMA patients 10–12 March, 2023, Hoofddorp, the Netherlands
Emanuela Abiusi, Mar Costa‐Roger, Enrico Bertini, et al.
Neuromuscular Disorders (2023) Vol. 34, pp. 114-122
Open Access | Times Cited: 6
Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective
Michelle A. Farrar, Loudella Calotes-Castillo, Ranil de Silva, et al.
Molecular and Cellular Pediatrics (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 5
MicroRNAs as Biomarkers in Spinal Muscular Atrophy
Maruša Barbo, Damjan Glavač, Gregor Jezernik, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2428-2428
Open Access | Times Cited: 1
The Relevance of Spinal Muscular Atrophy Biomarkers in the Treatment Era
Marianna Maretina, V. I. Koroleva, Л. М. Щугарева, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2486-2486
Open Access | Times Cited: 1
SMA Type II Skeletal Muscle Treated with Nusinersen shows SMN Restoration but Mitochondrial Deficiency.
Fiorella C. Grandi, Stéphanie Astord, Elèna Gidaja, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Characterization of SMA Type II Skeletal Muscle from Treated Patients shows Mitochondrial Deficiency and Denervation
Fiorella C. Grandi, Stéphanie Astord, Sonia Pezet, et al.
JCI Insight (2024) Vol. 9, Iss. 20
Open Access
High Expression of SMN circ4-2b-3 in SMA I Children Treated with Nusinersen is Associated with Improved Motor Outcomes
Marika Guerra, Alberto Marini, Vittoria Pagliarini, et al.
Molecular Neurobiology (2024)
Closed Access
Page 1

Scroll to top